Cameron Gray - Net Worth and Insider Trading
Cameron Gray Net Worth
The estimated net worth of Cameron Gray is at least $1 Million dollars as of 2024-11-13. Cameron Gray is the Director of Cue Biopharma Inc and owns about 677,500 shares of Cue Biopharma Inc (CUE) stock worth over $1 Million. Details can be seen in Cameron Gray's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cameron Gray has not made any transactions after 2020-09-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cameron Gray
Cameron Gray Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cameron Gray owns 2 companies in total, including Cue Biopharma Inc (CUE) , and Provention Bio Inc (PRVB) .
Click here to see the complete history of Cameron Gray’s form 4 insider trades.
Insider Ownership Summary of Cameron Gray
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CUE | Cue Biopharma Inc | 2020-09-30 | director |
| PRVB | Provention Bio Inc | 2018-07-03 | director |
Cameron Gray Latest Holdings Summary
Cameron Gray currently owns a total of 1 stock. Cameron Gray owns 677,500 shares of Cue Biopharma Inc (CUE) as of September 30, 2020, with a value of $1 Million.
Latest Holdings of Cameron Gray
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CUE | Cue Biopharma Inc | 2020-09-30 | 677,500 | 1.69 | 1,144,975 |
Holding Weightings of Cameron Gray
Cameron Gray Form 4 Trading Tracker
According to the SEC Form 4 filings, Cameron Gray has made a total of 1 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cue Biopharma Inc is the acquisition of 10,000 shares on September 30, 2020, which cost Cameron Gray around $151,500.
Insider Trading History of Cameron Gray
- 1
Cameron Gray Trading Performance
GuruFocus tracks the stock performance after each of Cameron Gray's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cameron Gray is -14.42%. GuruFocus also compares Cameron Gray's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cameron Gray within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cameron Gray's insider trading performs compared to the benchmark.
Performance of Cameron Gray
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -25.98 | | | | | |
| Relative Return to S&P 500(%) | -23.21 | | | | | |
Cameron Gray Ownership Network
Ownership Network List of Cameron Gray
Ownership Network Relation of Cameron Gray
Cameron Gray Owned Company Details
What does Cue Biopharma Inc do?
Who are the key executives at Cue Biopharma Inc?
Cameron Gray is the director of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include President and CSO Anish Suri , director & CEO Daniel R Passeri , and Chief Medical Officer Matteo Levisetti .
Cue Biopharma Inc (CUE) Insider Trades Summary
Over the past 18 months, Cameron Gray made no insider transaction in Cue Biopharma Inc (CUE). Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net purchase of 4,000 shares made by Anish Suri , and a net purchase of 3,000 shares made by Daniel R Passeri .
In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net purchase of 7,000 shares.
Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cue Biopharma Inc Insider Transactions
Cameron Gray Mailing Address
Above is the net worth, insider trading, and ownership report for Cameron Gray. You might contact Cameron Gray via mailing address: 40 Guest Street, Boston Ma 02135.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
